retatrutide is fda approved Warns Against Unapproved #Retatrutide Versions | CT Health News posted on the topic Retatrutide for weight loss: Study
Description
FDA 2022 5 2023 11 EMA TFDA [1] SURMOUNT 27 5,000 [10] 3 2.5 mg 4 15 mgSURMOUNT-1 5 mg 15% [1] 15 mg 6.2% 2.6% [11] SURMOUNT-4 2024 JAMA 36 52 89.5% 80% 14% [2] SURMOUNT-1 BMI 27 [1] BMI 30 TFDA 1
Recent headlines, like the Wall Street Journals coverage, highlight surging interest in new medications, along with growing concerns from the FDA regarding the use of compounded and unapproved versions of GLP-1-based treatments
30 GLP-1 has been shown to exert various anti-inflammatory actions on different tissues and can potentially be used for the treatment of several chronic inflammatory conditions like atherosclerosis, neurodegenerative disorders, diabetic nephropathy, asthma, psoriasis, and nonalcoholic steatohepatitis
)
It is the foundation for identifying health trends and is the international standard for reporting diseases and health conditions
The samples investigated were adequately sized to detect differences between groups, and individuals were followed for a relatively long time
How much, if any, grapefruit juice can you have
